Literature DB >> 23649848

Effects of smoking on D₂/D₃ striatal receptor availability in alcoholics and social drinkers.

Daniel S Albrecht1, David A Kareken, Karmen K Yoder.   

Abstract

Studies have reported lower striatal D₂/D₃ receptor availability in both alcoholics and cigarette smokers relative to healthy controls. These substances are commonly co-abused, yet the relationship between comorbid alcohol/tobacco abuse and striatal D₂/D₃ receptor availability has not been examined. We sought to determine the degree to which dual abuse of alcohol and tobacco is associated with lower D₂/D₃ receptor availability. Eighty-one subjects (34 nontreatment-seeking alcoholic smokers [NTS-S], 21 social-drinking smokers [SD-S], and 26 social-drinking non-smokers [SD-NS]) received baseline [(11)C]raclopride scans. D₂/D₃ binding potential (BPND ≡ Bavail/KD) was estimated for ten anatomically defined striatal regions of interest (ROIs). Significant group effects were detected in bilateral pre-commissural dorsal putamen, bilateral pre-commissural dorsal caudate; and bilateral post-commissural dorsal putamen. Post-hoc testing revealed that, regardless of drinking status, smokers had lower D₂/D₃ receptor availability than non-smoking controls. Chronic tobacco smokers have lower striatal D₂/D₃ receptor availability than non-smokers, independent of alcohol use. Additional studies are needed to identify the mechanisms by which chronic tobacco smoking is associated with striatal dopamine receptor availability.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23649848      PMCID: PMC3818334          DOI: 10.1007/s11682-013-9233-4

Source DB:  PubMed          Journal:  Brain Imaging Behav        ISSN: 1931-7557            Impact factor:   3.978


  66 in total

1.  Dopamine transporter and D2-receptor density in late-onset alcoholism.

Authors:  E Repo; J T Kuikka; K A Bergström; J Karhu; J Hiltunen; J Tiihonen
Journal:  Psychopharmacology (Berl)       Date:  1999-12       Impact factor: 4.530

2.  Enhanced dopamine release by nicotine in cigarette smokers: a double-blind, randomized, placebo-controlled pilot study.

Authors:  Hidehiko Takahashi; Yota Fujimura; Mika Hayashi; Harumasa Takano; Motoichiro Kato; Yoshiro Okubo; Iwao Kanno; Hiroshi Ito; Tetsuya Suhara
Journal:  Int J Neuropsychopharmacol       Date:  2007-10-22       Impact factor: 5.176

3.  Cerebral monoamine oxidase A inhibition in tobacco smokers confirmed with PET and [11C]befloxatone.

Authors:  Claire Leroy; Véronique Bragulat; Ivan Berlin; Marie-Claude Grégoire; Michel Bottlaender; Dimitri Roumenov; Frédéric Dollé; Sandrine Bourgeois; Jani Penttilä; Eric Artiges; Jean-Luc Martinot; Christian Trichard
Journal:  J Clin Psychopharmacol       Date:  2009-02       Impact factor: 3.153

4.  Striatal dopaminergic D(2) receptor density measured by [(123)I]iodobenzamide SPECT in the prediction of treatment outcome of alcohol-dependent patients.

Authors:  J Guardia; A M Catafau; F Batlle; J C Martín; L Segura; B Gonzalvo; G Prat; I Carrió; M Casas
Journal:  Am J Psychiatry       Date:  2000-01       Impact factor: 18.112

5.  Imaging human mesolimbic dopamine transmission with positron emission tomography. Part II: amphetamine-induced dopamine release in the functional subdivisions of the striatum.

Authors:  Diana Martinez; Mark Slifstein; Allegra Broft; Osama Mawlawi; Dah-Ren Hwang; Yiyun Huang; Thomas Cooper; Lawrence Kegeles; Eric Zarahn; Anissa Abi-Dargham; Suzanne N Haber; Marc Laruelle
Journal:  J Cereb Blood Flow Metab       Date:  2003-03       Impact factor: 6.200

6.  Imaging human mesolimbic dopamine transmission with positron emission tomography: I. Accuracy and precision of D(2) receptor parameter measurements in ventral striatum.

Authors:  O Mawlawi; D Martinez; M Slifstein; A Broft; R Chatterjee; D R Hwang; Y Huang; N Simpson; K Ngo; R Van Heertum; M Laruelle
Journal:  J Cereb Blood Flow Metab       Date:  2001-09       Impact factor: 6.200

7.  Treatment-naive active alcoholics have greater psychiatric comorbidity than normal controls but less than treated abstinent alcoholics.

Authors:  Victoria Di Sclafani; Peter Finn; George Fein
Journal:  Drug Alcohol Depend       Date:  2008-07-11       Impact factor: 4.492

Review 8.  Imaging dopamine's role in drug abuse and addiction.

Authors:  N D Volkow; J S Fowler; G J Wang; R Baler; F Telang
Journal:  Neuropharmacology       Date:  2008-06-03       Impact factor: 5.250

9.  When what you see isn't what you get: alcohol cues, alcohol administration, prediction error, and human striatal dopamine.

Authors:  Karmen K Yoder; Evan D Morris; Cristian C Constantinescu; Tee-Ean Cheng; Marc D Normandin; Sean J O'Connor; David A Kareken
Journal:  Alcohol Clin Exp Res       Date:  2008-10-31       Impact factor: 3.455

10.  Regional analysis of age-related decline in dopamine transporters and dopamine D2-like receptors in human striatum.

Authors:  Kenji Ishibashi; Kenji Ishii; Keiichi Oda; Keiichi Kawasaki; Hidehiro Mizusawa; Kiichi Ishiwata
Journal:  Synapse       Date:  2009-04       Impact factor: 2.562

View more
  9 in total

1.  Stressful life events are associated with striatal dopamine receptor availability in alcohol dependence.

Authors:  M Sebold; G Spitta; T Gleich; T Dembler-Stamm; O Butler; K Zacharias; S Aydin; M Garbusow; M Rapp; F Schubert; R Buchert; J Gallinat; A Heinz
Journal:  J Neural Transm (Vienna)       Date:  2019-02-12       Impact factor: 3.575

Review 2.  How Imaging Glutamate, γ-Aminobutyric Acid, and Dopamine Can Inform the Clinical Treatment of Alcohol Dependence and Withdrawal.

Authors:  Ansel T Hillmer; Graeme F Mason; Lisa M Fucito; Stephanie S O'Malley; Kelly P Cosgrove
Journal:  Alcohol Clin Exp Res       Date:  2015-10-28       Impact factor: 3.455

3.  Dopamine Transporter Gene Methylation is Associated with Nucleus Accumbens Activation During Reward Processing in Healthy but not Alcohol-Dependent Individuals.

Authors:  Christine Muench; Corinde E Wiers; Carlos R Cortes; Reza Momenan; Falk W Lohoff
Journal:  Alcohol Clin Exp Res       Date:  2017-11-27       Impact factor: 3.455

Review 4.  A review of positron emission tomography studies exploring the dopaminergic system in substance use with a focus on tobacco as a co-variate.

Authors:  Thulasi Thiruchselvam; Saima Malik; Bernard Le Foll
Journal:  Am J Drug Alcohol Abuse       Date:  2016-11-30       Impact factor: 3.829

Review 5.  Imaging addiction: D2 receptors and dopamine signaling in the striatum as biomarkers for impulsivity.

Authors:  Pierre Trifilieff; Diana Martinez
Journal:  Neuropharmacology       Date:  2013-07-10       Impact factor: 5.250

6.  Striatal Dopamine D2/D3 Receptor Availability Varies Across Smoking Status.

Authors:  Corinde E Wiers; Elizabeth A Cabrera; Dardo Tomasi; Christopher T Wong; Şükrü B Demiral; Sung Won Kim; Gene-Jack Wang; Nora D Volkow
Journal:  Neuropsychopharmacology       Date:  2017-06-23       Impact factor: 7.853

7.  Differences in White Matter Microstructure and Connectivity in Nontreatment-Seeking Individuals with Alcohol Use Disorder.

Authors:  Evgeny J Chumin; Joaquín Goñi; Meredith E Halcomb; Timothy C Durazzo; Mario Dzemidzic; Karmen K Yoder
Journal:  Alcohol Clin Exp Res       Date:  2018-04-14       Impact factor: 3.455

8.  Differences in IV alcohol-induced dopamine release in the ventral striatum of social drinkers and nontreatment-seeking alcoholics.

Authors:  Karmen K Yoder; Daniel S Albrecht; Mario Dzemidzic; Marc D Normandin; Lauren M Federici; Tammy Graves; Christine M Herring; Karen L Hile; James W Walters; Tiebing Liang; Martin H Plawecki; Sean O'Connor; David A Kareken
Journal:  Drug Alcohol Depend       Date:  2016-01-13       Impact factor: 4.492

Review 9.  Tobacco smoking and dopaminergic function in humans: a meta-analysis of molecular imaging studies.

Authors:  Abhishekh H Ashok; Yuya Mizuno; Oliver D Howes
Journal:  Psychopharmacology (Berl)       Date:  2019-03-18       Impact factor: 4.530

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.